Why is Johnson Pharma falling/rising?

As of 18-Aug, Johnson Pharmacare Ltd is currently priced at 0.78, showing no change (0.00%). The stock has underperformed its sector today by 1.85% and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Over the past month, the stock has declined by 10.34%, and year-to-date, it has dropped significantly by 31.58%. Additionally, the stock is close to its 52-week low, being only 2.56% away from a low of Rs 0.76. There has also been a notable decrease in investor participation, with delivery volume falling by 22.66% compared to the 5-day average, indicating reduced interest in trading the stock.
In the broader market context, Johnson Pharmacare's short-term performance has lagged behind the benchmark Sensex, which has gained 0.83% over the past week, while Johnson Pharma has remained flat. The stock's year-to-date performance is particularly concerning, with a decline of 31.58% compared to the Sensex's increase of 4.01%. This stark contrast highlights the challenges faced by Johnson Pharmacare in attracting investor confidence and maintaining market momentum, further exacerbated by its underperformance relative to the benchmark and sector.